 |
Lisa Ashby
President, Category Management, Cardinal Health |
 |
Tim Biro
CTO, Verium Diagnostics |
 |
R. Gregoire Blackmore
Chief Operating Officer,
Midmark |
 |
Thomas Boat, M.D.
Dean of College of Medicine, V.P. for Health Affairs, University of Cincinnati
|
 |
Mark A. Collar,
Partner, Triathlon
Medical Ventures
Chairman, Third Frontier Advisory Board |
 |
Anthony J. Dennis, Ph.D.
President & CEO,
BioOhio |
 |
Frank L. Douglas,
Ph.D., M.D.
President & CEO, Austen BioInnovation Institute in Akron
|
 |
Jacob Drapkin
Vice President, Reimbursement & Healthcare Economics
Ethicon Endo-Surgery, Inc.
|
 |
Kevin Driscoll, Ph.D.
Executive Director, Global Health Care R&D, Procter & Gamble |
 |
Brian Duncan, M.D.
Venture Partner, Arboretum Ventures
Vice President Business Development, BioEnterprise |
 |
John (Jack) Fisher
Executive Vice President, Ohio Farm Bureau Federation |
 |
John Gorski
President & CEO, NAMSA |
 |
Mike Hooven
President & CEO,
Enable Medical Technologies |
 |
Peter G. Kleinhenz
General Partner, CID Equity Partners &
Venture Partner,
Fletcher Spagt Ventures |
 |
Barbara Kunz
President, Health & Life Sciences, Global Division, Battelle |
 |
Jay Mazelsky
Sr. Vice President & General Manager, CT/NM, Philips Healthcare
|
 |
John M. Rice, Ph.D.
Chair
Managing Partner, Triathlon Medical Ventures |
 |
David R. Scholl, Ph.D. Retired Founder and President, Diagnostic Hybrids, Inc. |
 |
Mike Sieron
President & CEO,
DG Medical
|
 |
Caroline Whitacre, Ph.D.
Vice Chair
Vice President for Research,
The Ohio State University
|